High dose chemotherapy with stem cell rescue has been used in an attempt to
overcome chemotherapy resistance and increase survival in patients with po
or prognosis epithelial ovarian cancer. Untreated patients with advanced st
age disease and those with chemosensitive recurrent disease do better in te
rms of response rates as well as duration of response and overall survival.
Newer strategies using multiple cycles of dose intense therapy may improve
results although it will be difficult to document changes in the natural h
istory of advanced ovarian cancer without the completion of randomized phas
e ill trials. Curr Opin Obstet Gynecol 11:17-21. (C) 1999 Lippincott Willia
ms & Wilkins.